ETF · holdings as filed 2026-06-30

What's inside XPH?

State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF
Holdings
66
positions in the fund
Top 10
27%
of fund assets
Expense ratio
0.35%
net, per year
Fund size
$428M
total net assets
Sectors tap a row to see its top 10 holdings
Top holdings — Health Care
Your 10 largest positions in this sector
1
D
DFTXDEFINIUM THERAPEUTICS INC
2.84%
2
M
MBXMBX BIOSCIENCES INC
2.50%
3
A
ALMSALUMIS INC
1.97%
4
A
ATAIATAIBECKLEY INC
1.96%
5
T
TRVITREVI THERAPEUTICS INC
1.96%
6
E
ELVNENLIVEN THERAPEUTICS INC
1.93%
7
A
AMLXAMYLYX PHARMACEUTICALS INC
1.88%
8
M
MANEVERADERMICS INC
1.86%
9
L
LGNDLIGAND PHARMACEUTICALS
1.79%
10
N
NUVBNUVATION BIO INC
1.74%
Geography tap a row to see its top 10 holdings
Top holdings — United States
Your 10 largest positions in this country
1
G
GVMXXSTATE ST INST US GOV MM-PREM
7.96%
2
M
MBXMBX BIOSCIENCES INC
2.50%
3
A
ALMSALUMIS INC
1.97%
4
A
ATAIATAIBECKLEY INC
1.96%
5
T
TRVITREVI THERAPEUTICS INC
1.96%
6
E
ELVNENLIVEN THERAPEUTICS INC
1.93%
7
A
AMLXAMYLYX PHARMACEUTICALS INC
1.88%
8
M
MANEVERADERMICS INC
1.86%
9
L
LGNDLIGAND PHARMACEUTICALS
1.79%
10
N
NUVBNUVATION BIO INC
1.74%
Geography reflects each issuer's registered business address per SEC EDGAR filings where available, falling back to the exchange or listing where no SEC filing exists — not necessarily where a company's stock is primarily listed (e.g. TSMC is classified as Taiwan even though its ADR trades on the NYSE).
Hold XPH alongside other funds? See your combined true holdings, overlap, and blended fees — free, no signup.
Unwrap your portfolio →
Data source: official SEC Form N-PORT filings (as of 2026-06-30); expense ratio from SEC prospectus (risk/return) filings. Fund holdings are disclosed quarterly and may reflect a 60-day reporting delay.
Informational and educational only — not investment advice.